Regulation of the non-steroid anti-inflammatory drug «Diclofenac sodium» in the air environment of populated places
DOI:
https://doi.org/10.26641/2307-0404.2025.2.333685Ключевые слова:
diclofenac sodium, nonsteroidal anti-inflammatory drugs, toxicological studies, regulation, atmospheric airАннотация
The most common group of drugs today are non-steroidal anti-inflammatory drugs, among which diclofenac sodium is one of the most widely used. It has a pronounced anti-inflammatory, analgesic and moderate antipyretic effect by inhibiting the synthesis of prostaglandins. This active pharmaceutical ingredient belongs to the second class of the Biopharmaceutical classification system, which has a high degree of permeability through biological membranes, which leads to the possibility of absorption of diclofenac sodium already in the stomach, thereby causing unwanted side and negative effects. Considering the large volumes of production and possible serious side effects of this active pharmaceutical ingredient, it is advisable to control the level of this substance in atmospheric air. The purpose of this work was to scientifically substantiate the hygienic regulation of diclofenac sodium in the atmospheric air of populated areas based on studies of the toxicological properties of this active pharmaceutical ingredient. Experimental animals (102 non-linear white mice, 136 non-linear white rats of both sexes, 60 short-haired mice) were divided into experimental and control groups of 6 individuals each. Based on the obtained indicators of lethality of experimental animals, using the method of probit analysis, the indicators of toxicity during acute exposure of the substance were determined – semi-lethal dose with a single intragastric administration of DL50 for female rats (54.83 mg/kg), DL50 for mice (550 mg/kg), DL50 for rats-females (104.4 mg/kg), and CL50 for male rats (243.11 mg/m3), CL50 for mice (71.61 mg/m3). According to subchronic exposure, it was established that diclofenac sodium has supercumulative activity, since the cumulative coefficients for subacute administration to mice and rats are <1 (0.94 and 0.96, respectively). It was determined that this substance does not have a pronounced irritating effect on the mucous membrane of the eyes and does not exhibit allergenic properties. Does not cause sensitization of the body. It is shown that the possibility of developing acute poisoning from a single inhalation exposure to diclofenac sodium is unlikely, which is confirmed by the coefficient of the possibility of inhalation poisoning (СPIP=0.000032). In turn, the low value of the Limch indicator (1.18 mg/m3) indicates the real danger of developing chronic inhalation poisoning with diclofenac sodium. Zbiol is 60.7, which indicates a significant sign of the ability to accumulate in the body. Expressed cumulative properties of this substance increase the risk of chronic poisoning. The maximum one-time maximum permissible concentration (MPC) in the atmospheric air of populated areas at the level of 0.03 mg/m3 was determined and substantiated. Thus, it is expedient to control and monitor the air environment during the production of medicinal products in order to prevent diclofenac sodium from entering the sanitary protection zones.
Библиографические ссылки
ICH hаrmonised guideline biopharmaceutics clas¬sification system – based biowaivers M9. Final version Adopted on 20 November 2019 [Internet]. 2019 [cited 2024 May 06]. Available from: https://database.ich.org/sites/default/files/M9_Guideline_Step4_2019_1116.pdf
Imai T, Hazama K, Kosuge Y, Suzuki S, Oot-suka S. Preventive effect of rebamipide on NSAID-induced lower gastrointestinal tract injury using FAERS and JADER. Scientific reports. 2022;12(1):2631. doi: https://doi.org/10.1038/s41598-022-06611-y
Bocci G, Oprea TI, Benet LZ. State of the Art and Uses for the Biopharmaceutics Drug Disposition Clas-sification System (BDDCS): New Additions, Revisions, and Citation References. AAPS J. 2022 Feb 23;24(2):37. doi: https://doi.org/10.1208/s12248-022-00687-0
Erhirhie EO, Ihekwereme CP, Ilodigwe EE. Advances in acute toxicity testing: strengths, weaknesses and regulatory acceptance. Interdiscip Toxicol. 2018;11(1):5-12. doi: https://doi.org/10.2478/intox-2018-0001
Vohra F, Raut A. Comparative efficacy, safety, and tolerability of diclofenac and aceclofenacin muscu-loskeletal pain management: A systematic review. Indian J of Pain. 2019;30(1):1-69. doi: https://doi.org/10.4103/0970-5333.173431
Yehudina ED. [Nonsteroidal anti-inflammatory drugs: evidence of effectiveness, facts, myths]. Neurology aspects of treatment. 2021;3:20-1. Ukrainian.
[On the approval of state medical and sanitary standards for the permissible content of chemical and biological substances in the atmospheric air of populated areas. Order of the Ministry of Health of Ukraine dated 2024 May 10 No. 813] [Internet]. 2024 [cited 2024 Jul 14]. Ukrainian. Available from: https://zakon.rada.gov.ua/laws/show/z0763-24#Text
UNEP/WHO – United Nations Environment Pro-gramme/World Health Organization. State-of-the-Science of Endocrine Disrupting Chemicals [Internet]. 2012 [cited 2024 Oct 10]. Available from: https://www.unep.org/resources/publication/state-science-endocrine-disputing-chemicals-ipcp-2012
Diclofenac (sodium salt). Safety data sheet. Cayman chemical [Internet]. 2022 [cited 2024 May 24]. Available from: https://cdn.caymanchem.com/cdn/msds/70680m.pdf
Panchal N, Kaur M, Tharmatt A, Thakur S, Jain SK. Development, Characterization and Evaluation of Parenteral Formulation of Diclofenac Sodium. AAPS PharmSciTech. 2020;21(6):219. doi: https://doi.org/10.1208/s12249-020-01729-6
Diclofenac sodium. National Library of Medicine. National Center for Biotechnology Information [Internet]. 2022 [cited 2024 May 24]. Available from: https://pubchem.ncbi.nlm.nih.gov/compound/Diclofenac-sodium
[On approval of guidelines "Justification of the maximum permissible concentrations of drugs in the air of the working area and the atmospheric air of populated areas". Order of the MH of Ukraine dated 2005 Oct 21 No. 544]. [Internet] 2005 [cited 2024 Jun 22]. Ukrainian. Available from: https://zakon.rada.gov.ua/rada/show/v0544282-05#Text
Smith AJ. Guidelines for planning and conducting high-quality research and testing on animals. Lab Anim Res. 2020 Jul 10;36:21. doi: https://doi.org/10.1186/s42826-020-00054-0
Eyme KM, Carvalho L, Badr CE. Intranasal delivery of experimental compounds in orthotopic brain tumor mouse models. STAR Protocols. 2021;2(1):100290. doi: https://doi.org/10.1016/j.xpro.2020.100290
Halmi MI, Rahim MB, Othman AR. Estimation of LC50 and its Confidence Interval for the Effect of Ferrous Sulphate on Catla catla. JEMAT. 2018;6(1):21-3. doi: https://doi.org/10.54987/jemat.v6i1.402
Novosad NV. [Laboratory animals and technique of biological experiment]. Zaporizhzhia: ZNU; 2011. 85 р. Ukrainian.
Lim KS, et al. A method for the evaluation of cumulation and tolerance by the determination of acute and subchronic median effective doses. Arch Intern Phar-macodyn Ther. 1961;130:336-42.
Antomonov MYu. [Mathematical processing and analysis of medical and biological data]. Кyiv: MYCz "Medynform"; 2018. 579 р. Ukrainian.
Kim HS, Kang GH, Yang MJ, Ahn HJ, Han SC, Hwang JH. Toxicity of diclofenac sodium salt in Yucatan minipigs (Sus scrofa) following 4 weeks of daily intra-muscular administration. Toxicol Rep. 2021 Feb 26;8:557-570. doi: https://doi.org/10.1016/j.toxrep.2021.02.022
Nikolaieva YI, Hlavachek DO. [Study of acute toxicity parameters of Diclofenac sodium by different methods of administration]. Bulletin of the Vinnytsia National Medical University. 2023;27(4):548-53. Ukrainian. doi: https://doi.org/10.31393/reports-vnmedical-2023-27(4)-02
Patel JH, Thanagari BS, Fefar DT, Prajapati KS, Jivani BM, Thakor KB, et al. Haemato-biochemical alterations induced by diclofenac sodium toxicity in Swiss albino mice. Vet World. 2012;5(7):417-9. doi: https://doi.org/10.5455/vetworld.2012.417-419
Загрузки
Опубликован
Как цитировать
Выпуск
Раздел
Лицензия
Copyright (c) 2025 Medicni perspektivi

Это произведение доступно по лицензии Creative Commons «Attribution» («Атрибуция») 4.0 Всемирная.
Submitting manuscript to the journal "Medicni perspektivi" the author(s) agree with transferring copyright from the author(s) to publisher (including photos, figures, tables, etc.) editor, reproducing materials of the manuscript in the journal, Internet, translation into other languages, export and import of the issue with the author’s article, spreading without limitation of their period of validity both on the territory of Ukraine and other countries. This and other mutual duties of the author and all co-authors separately and editorial board are secured by written agreement by special form to use the article, the sample of which is presented on the site.
Author signs a written agreement and sends it to Editorial Board simultaneously with submission of the manuscript.



